PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1393462
PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1393462
The Europe uterine cancer drugs market is expected to reach USD 1,251,870.80 million by 2030 from USD 684,672.98 million in 2022, growing at a CAGR of 8.4% during the forecast period of 2023 to 2030.
Europe Uterine Cancer Drugs Market, By Cancer Type (Endometrial Cancer and Uterine Sarcoma), Treatment Type (Chemotherapy, Hormone Therapy, Targeted Therapy, Immunotherapy, and Others), Drug Type (Generic and Branded), Age Group (Adults and Geriatric), Route of Administration (Oral and Parenteral), End User (Hospitals, Cancer Centers, Specialty Clinics, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, and rest of Europe) - Industry Trends and Forecast to 2030.